Structural characterization of a new variant of the CYP2A6 gene (CYP2A6*1B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4C.

Structural characterization of a new variant of the CYP2A6 gene (CYP2A61B) apparently diagnosed as heterozygotes of CYP2A61A and CYP2A6*4C.

Item

http://www.wikidata.org/entity/Q30653370

Q30653370

about

Preliminary investigation of the contribution of CYP2A6, CYP2B6, and UGT1A9 polymorphisms on artesunate-mefloquine treatment response in Burmese patients with Plasmodium falciparum malaria.Identification of novel CYP2A6*1B variants: the CYP2A6*1B allele is associated with faster in vivo nicotine metabolism.PM frequencies of major CYPs in Asians and Caucasians.Associations of CYP2A6 genotype with smoking behaviors in southern China.Genetic influence of dopamine receptor, dopamine transporter, and nicotine metabolism on smoking cessation and nicotine dependence in a Japanese population.Pharmacogenetics of the major polymorphic metabolizing enzymes.Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms.Genetic variability in CYP2A6 and the pharmacokinetics of nicotine.CYP2A6 polymorphisms and risk for tobacco-related cancers.A review of smoking behavior and smokers evidence (chemical modification, inducing nicotine metabolism, and individual variations by genotype: dopaminergic function and personality traits).Distribution of polymorphic variants of CYP2A6 and their involvement in nicotine addiction.A nicotine C-oxidase gene (CYP2A6) polymorphism important for promoter activity.CYP2A6 genotyping methods and strategies using real-time and end point PCR platforms.Genetic polymorphisms in human CYP2A6 gene causing impaired nicotine metabolism Inter-gene correlation on oligonucleotide arrays: how much does normalization matter?Genetic polymorphisms of cytochrome P450 in patients with hepatitis C virus-associated hepatocellular carcinoma.Novel human CYP2A6 alleles confound gene deletion analysis.Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population.CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation.CYP2A6 gene polymorphism and personality traits for NEO-FFI on the smoking behavior of youths.Growth hormone does not alter CYP2A6 activity in growth hormone-deficient children.

P2860

Q34015980-24DB6B2D-28C0-466D-87A2-31BF20DD2BB0 Q34067100-A8541D8D-8C71-4490-809F-D95ED6FD192F Q34228441-9B8C5EB4-A405-4EEE-8B58-A1A86131AEA1 Q34778875-E739D436-216F-4D76-85B1-9C57B38AE736 Q35016329-13693CDD-732C-4041-952E-B12EE850EBF6 Q35067187-E4ADC738-314B-4E48-BB3F-DD20F72D18F7 Q35876954-436C3399-455C-4EEB-A656-F3164D974F6F Q36989832-524CE95D-80F4-40B8-83F2-D8A73FD1B7A3 Q37329175-11CC0270-9F45-4864-B529-B892EE0A2EA5 Q37605893-AC772A25-5514-4AE4-ADD4-93B9A0EEC760 Q38683483-E781C60B-9801-445E-A113-1604760B9992 Q40587899-6CC81598-DAE0-4DFF-91BF-2796962CD877 Q41927477-7CE6C80C-997D-4867-B959-0AF3139754F5 Q42284318-394AE5BE-72D2-4C0D-BA37-EC4DC304E471 Q42664210-89C71996-166E-4935-8393-3D949882E068 Q42994051-966E58A0-00C1-4E2D-BCF1-8D4E84CE19B5 Q44957920-46852E29-3218-4906-B1AE-8E88A30958E3 Q45915624-F305E43D-A443-43B4-98F6-DF61AB26B304 Q46886437-C2517A07-CC52-45A7-BFA4-3DAC63F7A6AA Q46952411-9A4038D3-4DF4-4CEE-B12B-9AC28454B510 Q46957533-F74EE243-898E-42CD-B58B-379C92484197

P2860

Structural characterization of a new variant of the CYP2A6 gene (CYP2A61B) apparently diagnosed as heterozygotes of CYP2A61A and CYP2A6*4C.

Item

http://www.wikidata.org/entity/Q30653370

description

2000 nî lūn-bûn

@nan

2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu